Quantcast

Latest Benign prostatic hyperplasia Stories

2014-10-22 16:27:57

With a device necessary for many medical conditions and surgeries, manufacturers of urinary catheters have a safe and stable source of revenue that can withstand the steepest of economic downturns. VANCOUVER, Oct. 22, 2014 /PRNewswire/ - According to in-depth reports from iData Research, the leading global authority on medical device market research, the combined U.S. and European markets for urological devices was valued at almost US$4.7 billion in 2013, with both Coloplast and...

2014-10-21 08:34:00

NEW YORK, Oct. 21, 2014 /PRNewswire/ -- Honoring one's Hispanic heritage is about more than just celebrating your roots, it is about bringing awareness of issues that affect your community. Prostate cancer is the most common cancer among Hispanic man, affecting 1-in-7 during their lifetime. Dr. David Samadi, chief of urology at Lennox Hill Hospital in New York City, is urging Latin women to have the men in their lives get a simple blood test as a way to screen their prostate health....

2014-10-07 23:05:16

With a device necessary for many medical conditions and surgeries, manufacturers of urinary catheters have a safe and stable source of revenue that can withstand the steepest of economic downturns, reports iData Research Vancouver, BC (PRWEB) October 07, 2014 According to in-depth reports from iData Research, the leading global authority on medical device market research, the combined U.S. and European markets for urological devices was valued at almost US$4.7 billion in 2013, with both...

2014-09-18 08:29:25

Key evaluation to inform the US Food and Drug Administration regulatory submission SYDNEY, Sept. 18, 2014 /PRNewswire/ -- Australian biomarker discovery company Minomic International Ltd will today launch an important US trial of its MiStat(TM) prostate cancer screening test, planning to achieve US Food and Drug Administration (FDA) regulatory approval upon completion. Minomic's proprietary MiStat(TM) technology is a screening assay capable of identifying the presence of a...

2014-09-03 08:27:14

Innovative Urolift procedure for treatment of BPH in men has minimal side effects NEW YORK, Sept. 3, 2014 /PRNewswire-USNewswire/ -- Symptoms of enlarged prostate affect millions of men, who suffer needlessly from frequent urination and difficulty emptying their bladder. Urinary tract obstruction from BPH can cause dangerous bladder problems in men including urinary retention, UTI and kidney failure. http://photos.prnewswire.com/prnvar/20140408/NY00250LOGO According to Dr. Alex...

2014-09-02 23:06:24

According to the European urological device market report by iData Research, over 1.6 million urological procedures will be performed by 2020 in Europe; this includes stone management, interventional BPH and nephrostomy procedures. Vancouver, BC (PRWEB) September 02, 2014 According to a new report by iData Research (http://www.idataresearch.com), the leading global authority in medical device market research, the European urological device market is expected to grow to over €2 billion...

2014-08-27 23:08:41

Catalent, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it is collaborating with privately held Australian biomarker research company, Minomic International Limited, to develop MIL-38, an antibody drug conjugate (ADC) for prostate cancer therapy. Under the agreement, Catalent will initially produce the antibody for a clinical study with a view to larger scale production subject...

2014-07-08 23:14:27

HealthTronics, Inc., a leading provider of integrated urological and interventional radiology products and services, has signed a distribution agreement through its Endocare, Inc. subsidiary with HS Medical, Inc. that expands HealthTronics’ technology portfolio to include a new, targeted ablation solution. Austin, Texas (PRWEB) July 08, 2014 HealthTronics, Inc., a leading provider of integrated urological and interventional radiology products and services, has signed a distribution...

2014-07-02 08:27:35

Testosterone Gel (1%), the Generic Equivalent to Vogelxo(TM) (testosterone) Gel, Expected to Increase Access for Patients Who Need It MAPLE GROVE, Minn., July 2, 2014 /PRNewswire/ -- Upsher-Smith Laboratories, Inc., today announced the launch of Testosterone Gel (1%), the generic of the newly Food and Drug Administration (FDA) approved Vogelxo((TM)) (testosterone) gel 1%, for topical use, CIII, and the first and only available generic testosterone replacement therapy (TRT) available in three...

2014-06-19 23:16:34

NCMA’s Santa Rosa Urology and Dr. Michael Lazar provide diagnostics, treatment and management of a full spectrum of urologic health conditions including bladder stones. (PRWEB) June 19, 2014 Bladder stones are exactly what they sound like; hard stone-like pieces of concentrated urine which have crystallized and clumped together. Interestingly enough, in developing nations, bladder stones are fairly common in children – and sadly, as a result of dehydration, infection and a low-protein...


Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.